Announcements
- Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
- Royalty Pharma Declares Second Quarter 2024 Dividend
- Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference
- Royalty Pharma Reports Q4 and Full Year 2023 Results
- Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024
- Royalty Pharma Announces Dividend Increase
- Royalty Pharma Highlights Accomplishments and Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference
- Royalty Pharma to Present at the Evercore ISI 6th Annual HealthCONx Conference
- Royalty Pharma and Teva Collaborate to Further Accelerate Olanzapine Lai Program
- Royalty Pharma Reports Third Quarter 2023 Results
More ▼
Key statistics
As of last trade Royalty Pharma PLC (RPD:STU) traded at 25.92, 7.78% above its 52-week low of 24.05, set on Nov 16, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 25.77 |
---|---|
High | 26.01 |
Low | 25.77 |
Bid | 26.08 |
Offer | 26.19 |
Previous close | 25.93 |
Average volume | 224.67 |
---|---|
Shares outstanding | 597.43m |
Free float | 424.65m |
P/E (TTM) | 11.03 |
Market cap | 16.72bn USD |
EPS (TTM) | 2.54 USD |
Annual div (ADY) | 0.7851 EUR |
---|---|
Annual div yield (ADY) | 3.03% |
Div ex-date | Feb 15 2024 |
Div pay-date | Mar 15 2024 |
Next div ex-date | May 16 2024 |
Next div pay-date | Jun 14 2024 |
Data delayed at least 15 minutes, as of Apr 24 2024.
More ▼